(Reuters) - Medtronic Inc said it agreed to pay $85 million to settle a shareholder lawsuit accusing it of making misleading statements concerning Infuse, a genetically engineered bone graft used in spinal surgery.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/YGIHSON-mzM/us-medtronic-settlement-idUSBRE82T1A920120330
Current news latest news top news recent news save money travel
No comments:
Post a Comment